Zezhong Xiong - Publications

Integrated Omics and Multicohort Analyses Identify an Enhancer Variant Linking Ferroptosis to Precision Therapy in Prostate Cancer.

Journal: Cancer research

Published: December 28, 2024

Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer.

Journal: Signal transduction and targeted therapy

Published: October 24, 2024

Development and validation of a comprehensive predictive model for surgical planning in patients with renal cell carcinoma and inferior vena cava tumor thrombus.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: August 30, 2024

PDIA2 is associated with the prognosis of prostate cancer, and downregulation of PDIA2 delays the progression of prostate cancer cells.

Journal: Scientific reports

Published: June 21, 2024

Comparing the diagnostic value of 68Ga-prostate-specific membrane antigen PET/CT and multiparametric MRI in pelvic lymph node metastasis of locally advanced prostate cancer.

Journal: Translational andrology and urology

Published: January 15, 2024

Oncogene goosecoid is transcriptionally regulated by E2F1 and correlates with disease progression in prostate cancer.

Journal: Chinese medical journal

Published: June 26, 2023

Integrating bioinformatic analysis and detailed experiments reveal an EMT-related biomarker for clear cell renal cell carcinoma.

Journal: Cancer medicine

Published: June 23, 2023

Targeting Alpha-Ketoglutarate Disruption Overcomes Immunoevasion and Improves PD-1 Blockade Immunotherapy in Renal Cell Carcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 27, 2023

Metabolic classifications of renal cell carcinoma reveal intrinsic connections with clinical and immune characteristics.

Journal: Journal of translational medicine

Published: January 08, 2023

GAS1RR, an immune-related enhancer RNA, is related to biochemical recurrence-free survival in prostate cancer.

Journal: Experimental biology and medicine (Maywood, N.J.)

Published: November 21, 2022

A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma.

Journal: PeerJ

Published: October 20, 2022

Clinical characteristics and risk factors of fatal patients with COVID-19: a retrospective cohort study in Wuhan, China.

Journal: BMC infectious diseases

Published: July 25, 2020